Multiple Chinese Firms Expand Global Phase III Trials To Japan

Rule Change Eases Moves

 
• By Dexter Jie Yan
  
global trials
Chinese drug makers bent on cracking open global markets through new trial programs • Source: Shutterstock

More from Clinical Trials

More from R&D